Company profile for Valink Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Valink is advancing a new generation of antibody-drug conjugates (ADCs) designed to more effectively target tumors while minimizing harm to healthy tissue. Recognizing the limitations of existing ADCs, Valink is reimagining their design to overcome drug resistance and expand treatment reach. Our next-generation bispecific ADCs precisely interact with tumor cells, achieving higher potency where it truly matters. Through this in...
Valink is advancing a new generation of antibody-drug conjugates (ADCs) designed to more effectively target tumors while minimizing harm to healthy tissue. Recognizing the limitations of existing ADCs, Valink is reimagining their design to overcome drug resistance and expand treatment reach. Our next-generation bispecific ADCs precisely interact with tumor cells, achieving higher potency where it truly matters. Through this innovative approach, we aim to deliver safer, more effective therapies for cancers that remain untreatable with current options.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Broadway, Cambridge, Massachusetts, 02142
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us
read-more

https://www.prnewswire.com/news-releases/nona-biosciences-and-valink-therapeutics-form-strategic-alliance-to-accelerate-novel-biologics-discovery-302644703.html

PR NEWSWIRE
17 Dec 2025

https://www.pharmiweb.com/press-release/2025-10-20/valink-therapeutics-closes-118-million-pre-a-financing-round-to-advance-oncology-pipeline

PHARMIWEB
20 Oct 2025

https://www.businesswire.com/news/home/20241218218235/en

BUSINESSWIRE
18 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty